Insider Transactions in Q1 2023 at Coherus Bio Sciences, Inc. (CHRS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,278
-12.27%
|
$97,668
$6.84 P/Share
|
|
Jan 20
2023
|
Dennis M Lanfear President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
86,250
+11.64%
|
-
|
|
Jan 20
2023
|
Mc David Stilwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.73%
|
-
|
|
Jan 20
2023
|
Vladimir Vexler Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+23.35%
|
-
|
|
Jan 20
2023
|
Bryan J Mc Michael Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+32.15%
|
-
|
|
Jan 11
2023
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,602
-3.79%
|
$36,020
$10.26 P/Share
|
|
Jan 10
2023
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,602
-3.66%
|
$32,418
$9.85 P/Share
|
|
Jan 07
2023
|
Bryan J Mc Michael Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,699
-10.9%
|
$15,291
$9.58 P/Share
|
|
Jan 04
2023
|
Mc David Stilwell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,437
-7.8%
|
$48,933
$9.87 P/Share
|
|
Jan 04
2023
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,437
-5.23%
|
$48,933
$9.87 P/Share
|
|
Jan 04
2023
|
Dennis M Lanfear President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,905
-1.88%
|
$98,145
$9.87 P/Share
|